{
  "meta": {
    "title": "21_Extravascular_Hemolysis",
    "url": "https://brainandscalpel.vercel.app/21-extravascular-hemolysis-50e31f7e.html",
    "scrapedAt": "2025-11-30T12:33:30.711Z"
  },
  "questions": [
    {
      "text": "The peripheral smear of a patient with chronic fatigue is shown below. This marked finding is seen in all of the conditions except",
      "choices": [
        {
          "id": 1,
          "text": "Sickle cell anemia"
        },
        {
          "id": 2,
          "text": "Hereditary spherocytosis"
        },
        {
          "id": 3,
          "text": "Paroxysmal nocturnal hemoglobinuria"
        },
        {
          "id": 4,
          "text": "Thalassemia"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given peripheral smear shows<strong> Howell&ndash;Jolly bodies</strong>. They are not seen in paroxysmal nocturnal hemoglobinuria.</p>\n<p>They<strong>&nbsp;</strong>are&nbsp;small nuclear remnants seen as&nbsp;inclusions in red cells and are <strong>characteristic</strong> of<strong> asplenia</strong>.&nbsp;They are seen in the following conditions:</p>\n<ul>\n<li>Sickle cell&nbsp;anaemia - due to auto splenectomy</li>\n<li>Hereditary spherocytosis</li>\n<li>Thalassemia post-splenectomy</li>\n</ul>\n<p>The images given below show Howell&ndash;Jolly bodies in peripheral&nbsp;blood smear.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4d01f70eb8ec4a6cbd79347cf771d171x799x596.PNG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/432a8af8c8dd4cc4bce045fffbfcc772x610x600.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/0bafaa69180342859842b864f136763e.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0363",
      "difficulty": "medium"
    },
    {
      "text": "Match the types of thalassemia with their most common mutations.<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td>1.&nbsp;&beta;+ thalassemia</td>\n<td>A. Terminator mutation</td>\n</tr>\n<tr>\n<td>2.&nbsp;&beta;<sup>0</sup> thalassemia</td>\n<td>B. Gene deletion</td>\n</tr>\n<tr>\n<td>3.&nbsp;&alpha; thalassemia</td>\n<td>C. Splicing mutation</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "1-C, 2-A, 3-B"
        },
        {
          "id": 2,
          "text": "1-C, 2-B, 3-A"
        },
        {
          "id": 3,
          "text": "1-A, 2-B, 3-C"
        },
        {
          "id": 4,
          "text": "1-B, 2-A, 3-C"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The most common types of mutations causing thalassemia are:</p>\n<table>\n<tbody>\n<tr>\n<td>Thalassemia</td>\n<td>Most common mutation</td>\n</tr>\n<tr>\n<td>&beta;+ thalassemia</td>\n<td>Splicing mutation</td>\n</tr>\n<tr>\n<td>&beta;<sup>0</sup>&nbsp;thalassemia</td>\n<td>Terminator mutation</td>\n</tr>\n<tr>\n<td>&alpha; thalassemia</td>\n<td>Gene deletion</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>The different splicing mutations are:</p>\n<ul>\n<li>Mutations that destroy the normal RNA splice junctions - completely prevent the production of normal &beta;-globin mRNA resulting in <strong>&beta;<sup>0</sup></strong>-thalassemia</li>\n<li>Mutations that create an ectopic splice site within an intron with normal splice regions - some normal &beta;-globin mRNA is made resulting in <strong>&beta;<sup>+</sup></strong> thalassemia</li>\n</ul>\n<p>There are two subtypes of chain terminator mutations:</p>\n<ul>\n<li>New stop codon within an exon</li>\n<li>Small insertions or deletions that shift the mRNA reading frames</li>\n</ul><hr><h3>Related Pearl: Thalassemia syndromes</h3><p>Normally each individual carries 4 functional alpha chain genes and 2 functional beta chain genes. Alpha and beta-thalassemia are inherited disorders in which there is reduced production of alpha-globin or beta-globin chains, respectively.</p>\n<ul>\n<li data-canvas-width=\"535.628896311106\"><strong>Alpha thalassemia:</strong> Gene deletion is the most common cause of reduced α-chain synthesis.</li>\n<li data-canvas-width=\"535.628896311106\"><strong>Beta +- thalassemia:</strong> The most common cause is splicing mutation.</li>\n<li data-canvas-width=\"535.628896311106\"><strong>Beta 0- thalassemia:</strong> Chain terminator mutations are the most common cause.</li>\n</ul>\n<p>The table below describes the features of typical thalassemia syndromes:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Alpha thalassemias</strong></td>\n<td><strong> Hb Barts</strong></td>\n<td><strong>HbH disease </strong></td>\n<td><strong>Minor</strong></td>\n<td><strong>Silent carrier</strong></td>\n</tr>\n<tr>\n<td><strong>Genotype</strong></td>\n<td>(- - / - - )</td>\n<td>\n<p>(α -/ - -)</p>\n<p>or</p>\n<p>(α<span>*</span> -/ - -)</p>\n</td>\n<td>\n<p>(α -/α -)</p>\n<p>or</p>\n<p>(α α/- -)</p>\n</td>\n<td>(α α/α -)</td>\n</tr>\n<tr>\n<td><strong>Laboratory findings</strong></td>\n<td>Severe microcytic anemia with hydrops fetalis; fatal in utero</td>\n<td>Moderate microcytic anemia</td>\n<td>Mild microcytic anemia</td>\n<td>Normal hemoglobin, normal MCV</td>\n</tr>\n<tr>\n<td><strong>Hemoglobin electro-phoresis</strong></td>\n<td>Hb Barts (γ globin tetramers); Hb Portland (embryonic hemoglobin); no HbF, HbA, or HbA<sub>2</sub></td>\n<td>HbH (beta-globin tetramers -up to 30%); HbA<sub>2 </sub>(up to 4%)</td>\n<td>Hb Barts (3 to 8%)</td>\n<td>Normal</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>\"-\" denotes deletion of an alpha gene and \"α\" denotes normal alpha gene and \"α* \" refers to a mutant alpha chain gene.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Beta thalassemias</strong></td>\n<td><strong>Major (transfusion-dependent)</strong></td>\n<td><strong>Intermedia (non-transfusion-dependent)</strong></td>\n<td><strong>Minor (also called trait or carrier)</strong></td>\n</tr>\n<tr>\n<td><strong>Genotype</strong></td>\n<td>\n<p>Homozygous</p>\n<p>β<sup>0</sup>/β<sup>0</sup></p>\n<p>or</p>\n<p>β<sup>0</sup>/β<sup>+</sup></p>\n<p>or</p>\n<p>β+/β+ </p>\n</td>\n<td>\n<p>Variable</p>\n<p>β0/β+</p>\n<p>or</p>\n<p>β<sup>+</sup>/β<sup>+</sup></p>\n<p>or</p>\n<p>β0/β</p>\n<p>or</p>\n<p>β+/β</p>\n</td>\n<td>\n<p>Heterozygous</p>\n<p>β<sup>0</sup>/β</p>\n<p>or</p>\n<p>β<sup>+</sup>/β</p>\n</td>\n</tr>\n<tr>\n<td><strong>Laboratory findings</strong></td>\n<td>Severe microcytic anemia with target cells (typical Hb 3 to 4 g/dL)</td>\n<td>Moderate microcytic anemia</td>\n<td>Mild microcytic anemia</td>\n</tr>\n<tr>\n<td><strong>Hemoglobin electrophoresis</strong></td>\n<td>HbA<sub>2 </sub>(5% or more); HbF (up to 95%); no HbA</td>\n<td>HbA<sub>2</sub> (4% or more); HbF (up to 50%)</td>\n<td>HbA<sub>2</sub> (4% or more); HbF (up to 5%)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>β<sup>0</sup> refers to no beta-globin production; β<sup>+</sup> refers to decreased beta-globin production.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA0313",
      "difficulty": "medium"
    },
    {
      "text": "Which chromosome is affected in alpha-thalassemia?",
      "choices": [
        {
          "id": 1,
          "text": "16"
        },
        {
          "id": 2,
          "text": "11"
        },
        {
          "id": 3,
          "text": "6"
        },
        {
          "id": 4,
          "text": "12"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Chromosome 16</strong>&nbsp;contains an identical pair of &alpha;-globin genes which is affected in <strong>alpha-thalassemia</strong>. This condition is due to <strong>decreased synthesis</strong> of <strong>alpha chains</strong>.&nbsp;</p>\n<p>The two <strong>&beta; chains</strong> are encoded by a single &beta;-globin gene on <strong>chromosome</strong> <strong>11</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA0312",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following statements is false regarding α-thalassemia?",
      "choices": [
        {
          "id": 1,
          "text": "Free β and γ chains are more soluble than free α chains"
        },
        {
          "id": 2,
          "text": "β tetramer is known as HbH"
        },
        {
          "id": 3,
          "text": "α chains are coded by a pair of genes"
        },
        {
          "id": 4,
          "text": "Hb Barts is the most severe form"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>&alpha; chains</strong> are coded by 4 genes i.e.&nbsp;<strong>two pairs </strong>of <strong>genes</strong> located on<strong> chromosome 16.</strong></p>\n<p>Free<strong> &beta;</strong> and <strong>&gamma;</strong> chains are <strong>more soluble</strong> than free &alpha; chains. They also form more stable homotetramers. Hence, hemolysis and dyserythropoiesis in&nbsp;&alpha; thalassemia are less severe when compared to&nbsp;&beta; thalassemia.</p>\n<p>In&nbsp;<strong>HbH disease</strong>,&nbsp;excess&nbsp;&beta;-globin&nbsp;chains form <strong>&beta;4 tetramers.</strong> They are seen in&nbsp;older children with&nbsp;&alpha;-thalassemia.</p>\n<p><strong>Hydrops fetalis</strong>&nbsp;is the <strong>most severe</strong> form of &alpha;-thalassemia. It is caused by the deletion of all four &alpha;-globin genes. This leads to excess &gamma;-globin chains forming&nbsp;&gamma;-globin&nbsp;tetramers (<strong>hemoglobin Barts</strong>).</p><hr><h3>Related Pearl: Thalassemia syndromes</h3><p>Normally each individual carries 4 functional alpha chain genes and 2 functional beta chain genes. Alpha and beta-thalassemia are inherited disorders in which there is reduced production of alpha-globin or beta-globin chains, respectively.</p>\n<ul>\n<li data-canvas-width=\"535.628896311106\"><strong>Alpha thalassemia:</strong> Gene deletion is the most common cause of reduced α-chain synthesis.</li>\n<li data-canvas-width=\"535.628896311106\"><strong>Beta +- thalassemia:</strong> The most common cause is splicing mutation.</li>\n<li data-canvas-width=\"535.628896311106\"><strong>Beta 0- thalassemia:</strong> Chain terminator mutations are the most common cause.</li>\n</ul>\n<p>The table below describes the features of typical thalassemia syndromes:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Alpha thalassemias</strong></td>\n<td><strong> Hb Barts</strong></td>\n<td><strong>HbH disease </strong></td>\n<td><strong>Minor</strong></td>\n<td><strong>Silent carrier</strong></td>\n</tr>\n<tr>\n<td><strong>Genotype</strong></td>\n<td>(- - / - - )</td>\n<td>\n<p>(α -/ - -)</p>\n<p>or</p>\n<p>(α<span>*</span> -/ - -)</p>\n</td>\n<td>\n<p>(α -/α -)</p>\n<p>or</p>\n<p>(α α/- -)</p>\n</td>\n<td>(α α/α -)</td>\n</tr>\n<tr>\n<td><strong>Laboratory findings</strong></td>\n<td>Severe microcytic anemia with hydrops fetalis; fatal in utero</td>\n<td>Moderate microcytic anemia</td>\n<td>Mild microcytic anemia</td>\n<td>Normal hemoglobin, normal MCV</td>\n</tr>\n<tr>\n<td><strong>Hemoglobin electro-phoresis</strong></td>\n<td>Hb Barts (γ globin tetramers); Hb Portland (embryonic hemoglobin); no HbF, HbA, or HbA<sub>2</sub></td>\n<td>HbH (beta-globin tetramers -up to 30%); HbA<sub>2 </sub>(up to 4%)</td>\n<td>Hb Barts (3 to 8%)</td>\n<td>Normal</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>\"-\" denotes deletion of an alpha gene and \"α\" denotes normal alpha gene and \"α* \" refers to a mutant alpha chain gene.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Beta thalassemias</strong></td>\n<td><strong>Major (transfusion-dependent)</strong></td>\n<td><strong>Intermedia (non-transfusion-dependent)</strong></td>\n<td><strong>Minor (also called trait or carrier)</strong></td>\n</tr>\n<tr>\n<td><strong>Genotype</strong></td>\n<td>\n<p>Homozygous</p>\n<p>β<sup>0</sup>/β<sup>0</sup></p>\n<p>or</p>\n<p>β<sup>0</sup>/β<sup>+</sup></p>\n<p>or</p>\n<p>β+/β+ </p>\n</td>\n<td>\n<p>Variable</p>\n<p>β0/β+</p>\n<p>or</p>\n<p>β<sup>+</sup>/β<sup>+</sup></p>\n<p>or</p>\n<p>β0/β</p>\n<p>or</p>\n<p>β+/β</p>\n</td>\n<td>\n<p>Heterozygous</p>\n<p>β<sup>0</sup>/β</p>\n<p>or</p>\n<p>β<sup>+</sup>/β</p>\n</td>\n</tr>\n<tr>\n<td><strong>Laboratory findings</strong></td>\n<td>Severe microcytic anemia with target cells (typical Hb 3 to 4 g/dL)</td>\n<td>Moderate microcytic anemia</td>\n<td>Mild microcytic anemia</td>\n</tr>\n<tr>\n<td><strong>Hemoglobin electrophoresis</strong></td>\n<td>HbA<sub>2 </sub>(5% or more); HbF (up to 95%); no HbA</td>\n<td>HbA<sub>2</sub> (4% or more); HbF (up to 50%)</td>\n<td>HbA<sub>2</sub> (4% or more); HbF (up to 5%)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>β<sup>0</sup> refers to no beta-globin production; β<sup>+</sup> refers to decreased beta-globin production.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA0317",
      "difficulty": "hard"
    },
    {
      "text": "A woman with an obstetric score of G3P2A0L0, in a consanguinous marriage, delivered a hydropic stillborn at 32 weeks of gestation.  Further evaluation revealed the presence of Hb Barts in the fetal blood. Which of the following globin chains tetramer is found in this condition?",
      "choices": [
        {
          "id": 1,
          "text": "α4"
        },
        {
          "id": 2,
          "text": "β4"
        },
        {
          "id": 3,
          "text": "γ4"
        },
        {
          "id": 4,
          "text": "δ4"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Hb Barts</strong> is a <strong>tetramer</strong> of <strong>&gamma;-globin</strong> chains (&gamma;4). This type of hemoglobin is seen in newborns with the most severe form of&nbsp;<strong>&alpha;-thalassemia </strong>and results in hemoglobin Barts<strong> hydrops fetalis. </strong>There is no production of&nbsp;&alpha; chains.</p>\n<p>Hb Barts has a higher affinity for oxygen. This leads to intrauterine hypoxia, eventually leading to stillbirth.</p>\n<p>The image given below shows (a) immature red cell precursors in peripheral smear and (b) stillborn hydropic infant in Hb Barts hydrops syndrome.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ef2a764ed38c45ab87df568361f3cecdx555x505.JPEG\" alt=\"Explanation Image\"><p>In <strong>HbH disease</strong>,&nbsp;excess<strong> &beta;-globin</strong> chains form &beta;4 tetramers. They are seen in&nbsp;older children with&nbsp;&alpha;-thalassemia.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA0315",
      "difficulty": "medium"
    },
    {
      "text": "A 26-year-old Chinese translator presents with fever, jaundice and splenomegaly. His Hb is 6 g% and peripheral smear with brilliant cresyl blue is given below. Which of the following globin chains would you expect to see in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "α4"
        },
        {
          "id": 2,
          "text": "β4"
        },
        {
          "id": 3,
          "text": "γ4"
        },
        {
          "id": 4,
          "text": "δ4"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario of <strong>extravascular hemolysis</strong>&nbsp;(jaundice and splenomegaly) and peripheral smear showing <strong>golf ball</strong> <strong>cells</strong> is suggestive of <strong>HBH disease</strong>. It is a type of <strong>&alpha; thalassemia</strong> where the HbH is composed of <strong>tetramers </strong>of<strong>&nbsp;&beta; chains </strong>(&beta;4).</p>\n<p>Hb-H disease is one type of alpha-thalassaemia with <strong>inactivation</strong> of <strong>3</strong> of the 4 <strong>alleles</strong>. It is more common in the <strong>Asian</strong> population. It usually manifests in the 1st year of life. It causes acute episodes of hemolysis when <strong>triggered</strong> by <strong>infections</strong> or oxidant <strong>drugs</strong>.</p>\n<p>The <strong>decreased &alpha; chain</strong> production leads to a relative <strong>excess</strong> of<strong> &beta; chains.</strong> This leads to the formation of <strong>HbH </strong>which has a <strong>high affinity</strong> for <strong>oxygen</strong>. Such RBCs are more prone to <strong>oxidation</strong> which causes <strong>precipitation</strong> of <strong>HbH</strong> to form <strong>golf ball inclusion</strong> bodies. This leads to increased sequestration and phagocytosis in the spleen.</p><hr><h3>Related Pearl: Thalassemia syndromes</h3><p>Normally each individual carries 4 functional alpha chain genes and 2 functional beta chain genes. Alpha and beta-thalassemia are inherited disorders in which there is reduced production of alpha-globin or beta-globin chains, respectively.</p>\n<ul>\n<li data-canvas-width=\"535.628896311106\"><strong>Alpha thalassemia:</strong> Gene deletion is the most common cause of reduced α-chain synthesis.</li>\n<li data-canvas-width=\"535.628896311106\"><strong>Beta +- thalassemia:</strong> The most common cause is splicing mutation.</li>\n<li data-canvas-width=\"535.628896311106\"><strong>Beta 0- thalassemia:</strong> Chain terminator mutations are the most common cause.</li>\n</ul>\n<p>The table below describes the features of typical thalassemia syndromes:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Alpha thalassemias</strong></td>\n<td><strong> Hb Barts</strong></td>\n<td><strong>HbH disease </strong></td>\n<td><strong>Minor</strong></td>\n<td><strong>Silent carrier</strong></td>\n</tr>\n<tr>\n<td><strong>Genotype</strong></td>\n<td>(- - / - - )</td>\n<td>\n<p>(α -/ - -)</p>\n<p>or</p>\n<p>(α<span>*</span> -/ - -)</p>\n</td>\n<td>\n<p>(α -/α -)</p>\n<p>or</p>\n<p>(α α/- -)</p>\n</td>\n<td>(α α/α -)</td>\n</tr>\n<tr>\n<td><strong>Laboratory findings</strong></td>\n<td>Severe microcytic anemia with hydrops fetalis; fatal in utero</td>\n<td>Moderate microcytic anemia</td>\n<td>Mild microcytic anemia</td>\n<td>Normal hemoglobin, normal MCV</td>\n</tr>\n<tr>\n<td><strong>Hemoglobin electro-phoresis</strong></td>\n<td>Hb Barts (γ globin tetramers); Hb Portland (embryonic hemoglobin); no HbF, HbA, or HbA<sub>2</sub></td>\n<td>HbH (beta-globin tetramers -up to 30%); HbA<sub>2 </sub>(up to 4%)</td>\n<td>Hb Barts (3 to 8%)</td>\n<td>Normal</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>\"-\" denotes deletion of an alpha gene and \"α\" denotes normal alpha gene and \"α* \" refers to a mutant alpha chain gene.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Beta thalassemias</strong></td>\n<td><strong>Major (transfusion-dependent)</strong></td>\n<td><strong>Intermedia (non-transfusion-dependent)</strong></td>\n<td><strong>Minor (also called trait or carrier)</strong></td>\n</tr>\n<tr>\n<td><strong>Genotype</strong></td>\n<td>\n<p>Homozygous</p>\n<p>β<sup>0</sup>/β<sup>0</sup></p>\n<p>or</p>\n<p>β<sup>0</sup>/β<sup>+</sup></p>\n<p>or</p>\n<p>β+/β+ </p>\n</td>\n<td>\n<p>Variable</p>\n<p>β0/β+</p>\n<p>or</p>\n<p>β<sup>+</sup>/β<sup>+</sup></p>\n<p>or</p>\n<p>β0/β</p>\n<p>or</p>\n<p>β+/β</p>\n</td>\n<td>\n<p>Heterozygous</p>\n<p>β<sup>0</sup>/β</p>\n<p>or</p>\n<p>β<sup>+</sup>/β</p>\n</td>\n</tr>\n<tr>\n<td><strong>Laboratory findings</strong></td>\n<td>Severe microcytic anemia with target cells (typical Hb 3 to 4 g/dL)</td>\n<td>Moderate microcytic anemia</td>\n<td>Mild microcytic anemia</td>\n</tr>\n<tr>\n<td><strong>Hemoglobin electrophoresis</strong></td>\n<td>HbA<sub>2 </sub>(5% or more); HbF (up to 95%); no HbA</td>\n<td>HbA<sub>2</sub> (4% or more); HbF (up to 50%)</td>\n<td>HbA<sub>2</sub> (4% or more); HbF (up to 5%)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>β<sup>0</sup> refers to no beta-globin production; β<sup>+</sup> refers to decreased beta-globin production.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/a0658cc1c6e448708608017dca5d1407.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0367",
      "difficulty": "medium"
    },
    {
      "text": "A patient has a HbA2 of 3% and HbF of 97%. A peripheral blood smear is taken. Which of the following blood pictures will be seen in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "1, 2 and 3"
        },
        {
          "id": 2,
          "text": "1 and 2"
        },
        {
          "id": 3,
          "text": "2 and 3"
        },
        {
          "id": 4,
          "text": "1 and 3"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The presence of <strong>HbA2 3% </strong>and<strong> HbF 97% </strong>indicates that it is a case of <strong>thalassemia major</strong>. In thalassemia major, hematological findings in image 1 showing <strong>poikilocytes</strong> and image 3 showing<strong> target cells</strong> are seen. Image 2 showing Howell Jolly bodies are seen in <strong>post-splenectomy</strong> thalassemia patients and not in this case.</p>\n<p><strong>Hematological findings</strong> in <strong>thalassemia major</strong> include the following:</p>\n<ul>\n<li>Anisopoikilocytosis</li>\n<li>Target cells (codocytes)</li>\n<li>Nucleated RBC’s</li>\n<li>Dacrocytes</li>\n<li>Basophilic stippling</li>\n<li>Polychromatophilic cells</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/418a6034a31647d8829d5b06f1c67d05x1280x1157.JPEG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9e9ac978c6984f2bb20c51348e10e8bdx1280x1280.JPEG\" alt=\"Explanation Image\"><img src=\"https://cdn1.dailyrounds.org/uploads/465c8ab170be4eed833399e831eaeaf8x345x235.PNG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Thalassemia syndromes</h3><p>Normally each individual carries 4 functional alpha chain genes and 2 functional beta chain genes. Alpha and beta-thalassemia are inherited disorders in which there is reduced production of alpha-globin or beta-globin chains, respectively.</p>\n<ul>\n<li data-canvas-width=\"535.628896311106\"><strong>Alpha thalassemia:</strong> Gene deletion is the most common cause of reduced α-chain synthesis.</li>\n<li data-canvas-width=\"535.628896311106\"><strong>Beta +- thalassemia:</strong> The most common cause is splicing mutation.</li>\n<li data-canvas-width=\"535.628896311106\"><strong>Beta 0- thalassemia:</strong> Chain terminator mutations are the most common cause.</li>\n</ul>\n<p>The table below describes the features of typical thalassemia syndromes:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Alpha thalassemias</strong></td>\n<td><strong> Hb Barts</strong></td>\n<td><strong>HbH disease </strong></td>\n<td><strong>Minor</strong></td>\n<td><strong>Silent carrier</strong></td>\n</tr>\n<tr>\n<td><strong>Genotype</strong></td>\n<td>(- - / - - )</td>\n<td>\n<p>(α -/ - -)</p>\n<p>or</p>\n<p>(α<span>*</span> -/ - -)</p>\n</td>\n<td>\n<p>(α -/α -)</p>\n<p>or</p>\n<p>(α α/- -)</p>\n</td>\n<td>(α α/α -)</td>\n</tr>\n<tr>\n<td><strong>Laboratory findings</strong></td>\n<td>Severe microcytic anemia with hydrops fetalis; fatal in utero</td>\n<td>Moderate microcytic anemia</td>\n<td>Mild microcytic anemia</td>\n<td>Normal hemoglobin, normal MCV</td>\n</tr>\n<tr>\n<td><strong>Hemoglobin electro-phoresis</strong></td>\n<td>Hb Barts (γ globin tetramers); Hb Portland (embryonic hemoglobin); no HbF, HbA, or HbA<sub>2</sub></td>\n<td>HbH (beta-globin tetramers -up to 30%); HbA<sub>2 </sub>(up to 4%)</td>\n<td>Hb Barts (3 to 8%)</td>\n<td>Normal</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>\"-\" denotes deletion of an alpha gene and \"α\" denotes normal alpha gene and \"α* \" refers to a mutant alpha chain gene.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Beta thalassemias</strong></td>\n<td><strong>Major (transfusion-dependent)</strong></td>\n<td><strong>Intermedia (non-transfusion-dependent)</strong></td>\n<td><strong>Minor (also called trait or carrier)</strong></td>\n</tr>\n<tr>\n<td><strong>Genotype</strong></td>\n<td>\n<p>Homozygous</p>\n<p>β<sup>0</sup>/β<sup>0</sup></p>\n<p>or</p>\n<p>β<sup>0</sup>/β<sup>+</sup></p>\n<p>or</p>\n<p>β+/β+ </p>\n</td>\n<td>\n<p>Variable</p>\n<p>β0/β+</p>\n<p>or</p>\n<p>β<sup>+</sup>/β<sup>+</sup></p>\n<p>or</p>\n<p>β0/β</p>\n<p>or</p>\n<p>β+/β</p>\n</td>\n<td>\n<p>Heterozygous</p>\n<p>β<sup>0</sup>/β</p>\n<p>or</p>\n<p>β<sup>+</sup>/β</p>\n</td>\n</tr>\n<tr>\n<td><strong>Laboratory findings</strong></td>\n<td>Severe microcytic anemia with target cells (typical Hb 3 to 4 g/dL)</td>\n<td>Moderate microcytic anemia</td>\n<td>Mild microcytic anemia</td>\n</tr>\n<tr>\n<td><strong>Hemoglobin electrophoresis</strong></td>\n<td>HbA<sub>2 </sub>(5% or more); HbF (up to 95%); no HbA</td>\n<td>HbA<sub>2</sub> (4% or more); HbF (up to 50%)</td>\n<td>HbA<sub>2</sub> (4% or more); HbF (up to 5%)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>β<sup>0</sup> refers to no beta-globin production; β<sup>+</sup> refers to decreased beta-globin production.</p><hr><h3>Related Pearl: Features of Peripheral Blood Smear in Different Anemias</h3><p><strong>Type of anemia </strong></p>\n<p><strong>Microcytic anemia</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Diagnosis</strong></p>\n</td>\n<td>\n<p><strong>Peripheral blood smear</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Thalassemia trait</p>\n</td>\n<td>\n<p>Basophilic stippling, target cells&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Iron-deficiency</p>\n</td>\n<td>\n<p>Elliptocytes, target cells</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Sideroblastic anemia</p>\n</td>\n<td>\n<p>Pappenheimer bodies, RBC dimorphism, ringed sideroblasts (Perl&rsquo;s stain)&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Macrocytic anemia</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Diagnosis</strong></p>\n</td>\n<td>\n<p><strong>Peripheral blood smear</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Myelodysplastic syndrome</p>\n</td>\n<td>\n<p>Hypogranular or hypolobulated neutrophils, blast cells, giant or hypogranular platelets, Pappenheimer bodies</p>\n<p>Minor population of hypochromic / microcytic cells (dimorphic), poikilocytosis&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Megaloblastic anemia</p>\n</td>\n<td>\n<p>Hypersegmented neutrophils (&gt;5 lobes), ovalocytes</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hemolysis</p>\n</td>\n<td>\n<p>Polychromasia (purple reticulocyte) +/- spherocytes&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chronic liver disease</p>\n</td>\n<td>\n<p>Target cells&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Normocytic anemia</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Diagnosis</strong></p>\n</td>\n<td>\n<p><strong>Peripheral blood smear</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Haemolytic anemia&nbsp;</p>\n</td>\n<td>\n<p>Anisocytosis, poikilocytosis, polychromasia, nucleated red cells&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hereditary spherocytosis</p>\n</td>\n<td>\n<p>RBC lack central zone of pallor, reticulocytosis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Glucose-6-Phosphate-Dehydrogenase (G6PD) deficiency&nbsp;</p>\n</td>\n<td>\n<p>Heinz bodies (revealed by special staining),&lsquo;Bite&rsquo; cells</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/09914ebca8144a6386f65ddd0243551a.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9163",
      "difficulty": "medium"
    },
    {
      "text": "Given below is the hemogram of a patient. Calculate the Mentzer index.<div class='question-desc-html'><p>Hb - 10 g%</p>\n<p>RBC - 6 million/mm<sup>3</sup></p>\n<p>Reticulocyte count - 0.6%</p>\n<p>MCV - 60 fL</p>\n<p>MCH - 20 pg</p>\n<p>Peripheral smear - microcytic hypochromic picture</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "10"
        },
        {
          "id": 2,
          "text": "12"
        },
        {
          "id": 3,
          "text": "30"
        },
        {
          "id": 4,
          "text": "6"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><span class=\"TextRun SCXW148009661\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW148009661\">From the given hemogram, the <strong>Mentzer</strong></span></span><span class=\"TextRun SCXW148009661\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW148009661\"><strong>&nbsp;index</strong>&nbsp;</span></span><span class=\"TextRun SCXW148009661\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW148009661\">is <strong>10</strong>. </span></span></p>\n<p><span class=\"TextRun SCXW148009661\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW148009661\">The formula for Mentzer index is <strong>MCV (fL) / TRBC (millions/mm<sup>3</sup>)</strong>&nbsp;i.e. 60/6 = 10</span></span></p>\n<p><span class=\"TextRun SCXW148009661\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW148009661\">This index is used to <strong>differentiate</strong> between <strong>i</strong></span></span><strong><span class=\"TextRun SCXW148009661\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW148009661\">ron-deficiency&nbsp;</span></span><span class=\"TextRun SCXW148009661\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"SpellingError SCXW148009661\">anemia</span></span></strong><span class=\"TextRun SCXW148009661\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW148009661\">&nbsp;and <strong>beta-thalassemia trait</strong>. If the index is&nbsp;</span></span><span class=\"TextRun SCXW148009661\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW148009661\"><strong>&lt;13</strong>, it is most likely to be a <strong>thalassemia</strong> trait.</span></span><span class=\"EOP SCXW148009661\" data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">&nbsp;</span></p>\n<p><span class=\"EOP SCXW148009661\" data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">Differences between iron deficiency anemia and beta-thalassemia minor (<span class=\"TextRun SCXW148009661\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW148009661\">beta-thalassemia trait)</span></span> are given below.</span></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Feature&nbsp; &nbsp;</strong></td>\n<td><strong><span class=\"TextRun SCXW148009661\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW148009661\">Iron-deficiency&nbsp;</span></span><span class=\"TextRun SCXW148009661\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"SpellingError SCXW148009661\">anemia</span></span></strong></td>\n<td><span class=\"EOP SCXW148009661\" data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\"><strong>Beta-thalassemia minor</strong></span></td>\n</tr>\n<tr>\n<td>Peripheral blood smear&nbsp;</td>\n<td>Microcytic hypochromic&nbsp;</td>\n<td>Microcytic&nbsp;hypochromic&nbsp;</td>\n</tr>\n<tr>\n<td>Retic&nbsp;count&nbsp;</td>\n<td>Low&nbsp;</td>\n<td>Low&nbsp;</td>\n</tr>\n<tr>\n<td>RDW&nbsp;</td>\n<td>Wide&nbsp;</td>\n<td>Narrow&nbsp;</td>\n</tr>\n<tr>\n<td>TRBC&nbsp;</td>\n<td>Low&nbsp;</td>\n<td>High&nbsp;</td>\n</tr>\n<tr>\n<td>Mentzer&nbsp;index&nbsp;</td>\n<td>&gt;14&nbsp;</td>\n<td>&lt;12&nbsp;</td>\n</tr>\n<tr>\n<td>Serum ferritin&nbsp;</td>\n<td>Low&nbsp;</td>\n<td>Normal</td>\n</tr>\n<tr>\n<td>Serum iron&nbsp;</td>\n<td>Low&nbsp;</td>\n<td>Normal&nbsp;</td>\n</tr>\n<tr>\n<td>TIBC&nbsp;</td>\n<td>High&nbsp;</td>\n<td>Normal</td>\n</tr>\n<tr>\n<td>HbA2&nbsp;</td>\n<td>\n<p>2-3%</p>\n<p>(normal)</p>\n</td>\n<td>&gt;3.5%&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0372",
      "difficulty": "easy"
    },
    {
      "text": "The following test was performed with blood sample from a patient with anaemia. What is this test used for?",
      "choices": [
        {
          "id": 1,
          "text": "Detection of sickle cell trait"
        },
        {
          "id": 2,
          "text": "Screening of thalassemia"
        },
        {
          "id": 3,
          "text": "Confirmatory test for hereditary spherocytosis"
        },
        {
          "id": 4,
          "text": "Bedside diagnostic test for PNH"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given image shows&nbsp;<strong>NESTROFT</strong> i.e. Naked Eye Single Tube Red cell Osmotic Fragility test.&nbsp;It is a very useful <strong>screening</strong> tool for <strong>thalassemia</strong>,&nbsp;particularly in poor&nbsp;resource settings.</p>\n<p>The principle is based on the <strong>decreased</strong> osmotic fragility of red cells in thalassemia. It is performed as follows:</p>\n<ol>\n<li>Mix EDTA blood and&nbsp;<strong>0.36% buffered saline </strong>solution.</li>\n<li>Shake the tube and leave it at room temperature for 30 minutes.</li>\n<li>Shake the tube again and immediately hold the tube in front of a piece of paper with text or lines.</li>\n</ol>\n<table>\n<tbody>\n<tr>\n<td><strong>NESTROFT</strong></td>\n<td><strong>Inference</strong></td>\n<td><strong>Reason</strong></td>\n</tr>\n<tr>\n<td>Lines visible (negative)</td>\n<td>Normal</td>\n<td>Hemolysis has occurred</td>\n</tr>\n<tr>\n<td>Lines not seen (positive)</td>\n<td>Thalassemia</td>\n<td>Stable RBC, unable to lyse</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>The image given below shows the NESTROFT.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6765ac0ca08c4311ae71aec4ddbce08ax360x604.PNG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/bdb5f53824364b4586f51ac3655169d1.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0369",
      "difficulty": "easy"
    },
    {
      "text": "A couple with a family history of thalassemia comes for genetic counselling. Their HPLC reports are given below. What is the risk of their offspring having thalassemia major?<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td><strong>Patient</strong></td>\n<td><strong>HbA2 levels</strong></td>\n</tr>\n<tr>\n<td>Husband</td>\n<td>2.5%</td>\n</tr>\n<tr>\n<td>Wife</td>\n<td>4.9%</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "0"
        },
        {
          "id": 2,
          "text": "25"
        },
        {
          "id": 3,
          "text": "50"
        },
        {
          "id": 4,
          "text": "75"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>In the given clinical scenario, the <strong>risk</strong> of their offspring having <strong>thalassemia</strong> major is <strong>0%.&nbsp;</strong></p>\n<p>From the given HPLC reports, the&nbsp;<strong>husband</strong> is <strong>normal</strong> (normal value of HbA2 is 2.5%&plusmn;0.3%) and the <strong>wife</strong> has&nbsp;<strong>&beta;&nbsp;</strong><strong>thalassemia minor</strong> (HbA2 level 4.9%). This disease is transmitted with an <strong>autosomal recessive</strong> inheritance. Hence, the&nbsp;chance of their offspring having&nbsp;full blown thalassemia is zero.&nbsp;</p>\n<p>In&nbsp;<strong>&beta;&nbsp;</strong><strong>thalassemia</strong> <strong>minor</strong>, the&nbsp;Hb&nbsp;A2 levels are increased to 4&ndash;8%. This is due to an <strong>elevated</strong> ratio of <strong>&delta; chain</strong>&nbsp;to&nbsp;&beta;<strong>&nbsp;</strong>chain synthesis.&nbsp;Hb&nbsp;F levels are&nbsp;generally normal or slightly&nbsp;increased.</p>\n<p>Note: Increased HbF (diagnostic) and normal HbA2 levels are features of thalassemia major.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0365",
      "difficulty": "hard"
    },
    {
      "text": "A 25-year old man presents with chronic anemia and gall stones. His family history is significant for a similar illness. His peripheral blood smear is given below. What is the mode of the inheritance of the given clinical condition?",
      "choices": [
        {
          "id": 1,
          "text": "Autosomal dominant"
        },
        {
          "id": 2,
          "text": "Autosomal recessive"
        },
        {
          "id": 3,
          "text": "X-linked dominant"
        },
        {
          "id": 4,
          "text": "X-linked recessive"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given peripheral smear showing&nbsp;<strong>spherocytes,&nbsp;</strong>along with the history, is suggestive of&nbsp;<strong>hereditary spherocytosis.&nbsp;</strong>Inheritance of this condition is mainly&nbsp;<strong>autosomal dominant</strong>.</p>\n<p>Hereditary spherocytosis is a structural RBC disorder making the <strong>RBCs</strong> more <strong>spheroid</strong>. The RBCs are <strong>less deformable</strong> and more vulnerable to splenic sequestration and destruction. This <strong>decreases</strong> the <strong>lifespan</strong> of RBCs.</p><hr><h3>Related Pearl: Inheritance pattern of important diseases</h3><table class=\"t1\">\n<tbody>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>Autosomal dominant</strong></span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>Autosomal recessive</strong></span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>HEAV</strong>y<strong> DOMINANT</strong></span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>ABC DEF GHI</strong></span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>H</strong>: <strong>H</strong>ereditary spherocytosis, <strong>H</strong>ypercholesterolemia,&nbsp;<strong>H</strong>ypertrophic obstructive cardiomyopathy,&nbsp; <strong>H</strong>untington&rsquo;s disease</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span><strong>A</strong>: <strong>A</strong>taxia-telangiectasia,&nbsp;<strong>A</strong>lbinism, <strong>A</strong>lkaptonuria,&nbsp;</span></div>\n</div>\n<div class=\"p1\"><span><strong>A</strong>utosomal-recessive polycystic kidney disease</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>E</strong>: <strong>E</strong>hler-Danlos syndrome</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>B</strong>: <strong>B</strong>lood disorders like&nbsp;<strong>b</strong>eta-thalassemia and sickle-cell anemia</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>A</strong>: <strong>A</strong>chondroplasia</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span><strong>C</strong>: <strong>C</strong>ystic fibrosis,&nbsp;</span></div>\n</div>\n<div class=\"p1\"><span><strong>C</strong>ongenital adrenal hyperplasia</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>V</strong>: <strong>V</strong>on Willebrand disease, Von Hippel Lindau disease</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>D</strong>: Sensorineural <strong>d</strong>eafness</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>D</strong>: <strong>D</strong>ystrophia myotonica</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span><strong>E</strong>: <strong>E</strong>mphysema&nbsp;</span></div>\n</div>\n<div class=\"p1\"><span>(alpha1- antitrypsin deficiency)</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>O</strong>: <strong>O</strong>steogenesis imperfecta,&nbsp;<strong>O</strong>tosclerosis (variable)</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>F</strong>: <strong>F</strong>riedrich ataxia</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>M</strong>: <strong>M</strong>arfans syndrome, Multiple endocrine neoplasias (MEN)</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>G</strong>: <strong>G</strong>aucher&rsquo;s disease, <strong>G</strong>alactosemia, glycogen storage diseases</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>I</strong>: <strong>I</strong>ntermittent porphyria</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>H</strong>: <strong>H</strong>omocystinuria, <strong>H</strong>emochromatosis</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>N</strong>: <strong>N</strong>eurofibromatosis 1 and 2</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>I</strong>: <strong>I</strong>nborn errors of metabolism- Phenylketonuria, lysosomal storage diseases</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\"><span><strong>A</strong>: <strong>A</strong>utosomal-dominant polycystic kidney disease</span></td>\n<td class=\"td1\" valign=\"top\">Other conditions: Wilson's disease, sickle cell anemia, thalassemias, spinal muscular atrophy, Kartagener syndrome,&nbsp;</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\"><span><strong>N</strong>: <strong>N</strong>oonan's syndrome</span></td>\n<td class=\"td1\" valign=\"top\">Mucopolysaccharidoses (except Hunter syndrome)</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\"><span><strong>T</strong>: <strong>T</strong>uberous sclerosis</span></td>\n<td class=\"td1\" valign=\"top\">Sphingolipidoses (except Fabry disease)</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\"><span>Other conditions:<strong>&nbsp;</strong>Familial adenomatous polyposis, Hereditary hemorrhagic telangiectasia, Li-Fraumeni syndrome, Pseudohypoparathyroidism</span></td>\n<td class=\"td1\" valign=\"top\">&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><table class=\"t1\">\n<tbody>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>X-linked recessive</strong></span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>X-linked dominant</strong></span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>Lady Hardinge College Girls Don&rsquo;t Care About Foolish Words</strong></span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>Red Rose </strong>for<strong> All Children</strong></span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span>(<strong>L</strong>ady) <strong>L</strong>esch&ndash;Nyhan syndrome,&nbsp;<strong>L</strong>owe syndrome</span></div>\n</div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>R</strong>ed) <strong>R</strong>ett&rsquo;s syndrome</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>H</strong>ardinge) <strong>H</strong>unter's syndrome, <strong>H</strong>emophilia A and B</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>R</strong>ose) <strong>R</strong>ickets</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>C</strong>ollege) <strong>C</strong>hronic granulomatous disease</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div><span>(<strong>A</strong>ll) <strong>A</strong>lport syndrome&nbsp;(common inheritance pattern)</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>G</strong>irls) <strong>G</strong>-6-PD deficiency</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>C</strong>hildren) Type X <strong>C</strong>harcot&ndash;Marie&ndash;Tooth disease</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>D</strong>on&rsquo;t) <strong>D</strong>uchenne muscular dystrophy, <strong>D</strong>iabetes insipidus</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">&nbsp;</div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>C</strong>are) <strong>C</strong>olor blindness</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p2\">&nbsp;</div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span>(<strong>A</strong>bout) <strong>A</strong>gammaglobulinemia,&nbsp;<strong>A</strong>lport syndrome, Ocular&nbsp;<strong>a</strong>lbinism</span></div>\n</div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p2\">&nbsp;</div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(Foolish)&nbsp;<strong>F</strong>abry disease</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">&nbsp;</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>W</strong>ords) <strong>W</strong>iskott&ndash;Aldrich syndrome</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">&nbsp;</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span>Other conditions: Menke's disease,&nbsp;</span>Ornithine transcarbamylase deficiency</div>\n</div>\n</td>\n<td class=\"td1\" valign=\"top\">&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><span>&nbsp;</span></p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/389a11395c43424c8d2d65d3b620d60b.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA0292",
      "difficulty": "medium"
    },
    {
      "text": "What is the most common protein deficiency associated with hereditary spherocytosis?",
      "choices": [
        {
          "id": 1,
          "text": "Spectrin"
        },
        {
          "id": 2,
          "text": "Ankyrin"
        },
        {
          "id": 3,
          "text": "Actin"
        },
        {
          "id": 4,
          "text": "Glycophorin"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Ankyrin</strong> is the <strong>most common</strong> protein deficiency associated with<strong> hereditary spherocytosis</strong> (HS).</p>\n<p>The chief protein component of the RBC membrane skeleton is&nbsp;<strong>spectrin.</strong>&nbsp;It consists of two polypeptide chains, alpha and beta. These dimers associate with actin oligomers. The spectrin&ndash;actin skeleton is then connected to the cell membrane by two distinct interactions.</p>\n<ul>\n<li><strong>Ankyrin </strong>and<strong> band 4.2</strong>&nbsp;binds spectrin to the transmembrane ion transporter,&nbsp;<strong>band 3</strong></li>\n<li><strong>Protein 4.1</strong>&nbsp;binds the <strong>tail of spectrin</strong> to the transmembrane protein <strong>glycophorin A</strong></li>\n</ul>\n<p>Defect in any of the components of the red cell membrane skeleton results in hereditary spherocytosis.&nbsp;The image given below shows the pathogenesis of this condition.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/421cf4d19962443a895060d99edfd3cex1280x1991.JPEG\" alt=\"Explanation Image\"><p><strong>Note: </strong>Few one-liners on membrane skeleton -</p>\n<ul>\n<li>Most abundant integral proteins -&nbsp;<strong>glycophorin, band 3&nbsp;</strong></li>\n<li>Responsible for biconcave shape of RBC -&nbsp;<strong>spectrin</strong></li>\n<li>Most severe deficiency -&nbsp;<strong>spectrin</strong></li>\n<li>Hereditary elliptocytosis is due to deficiency of&nbsp;<strong>alpha spectrin</strong></li>\n<li>Mushroom cells appearance due to deficiency of&nbsp;<strong>band 3</strong></li>\n<li>Never involved in HS -&nbsp;<strong>glycophorin</strong></li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0300",
      "difficulty": "easy"
    },
    {
      "text": "The peripheral smear of a patient with anaemia, jaundice and splenomegaly shows pincer cells. Which protein deficiency is responsible for this finding?",
      "choices": [
        {
          "id": 1,
          "text": "α spectrin"
        },
        {
          "id": 2,
          "text": "Ankyrin"
        },
        {
          "id": 3,
          "text": "Band 3"
        },
        {
          "id": 4,
          "text": "Band 4.1"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><span class=\"TextRun SCXW185313120\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW185313120\"><strong>Pincer cell</strong> or <strong>mushroom cell</strong></span></span><span class=\"TextRun SCXW185313120\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW185313120\">&nbsp;is seen in&nbsp;<strong>hereditary spherocytosis</strong> associated with <strong>deficiency</strong> of&nbsp;</span></span><span class=\"TextRun SCXW185313120\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW185313120\">cytoskeletal protein</span></span><strong><span class=\"TextRun SCXW185313120\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW185313120\">&nbsp;</span></span></strong><span class=\"TextRun SCXW185313120\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW185313120\"><strong>band 3</strong>.</span></span><span class=\"EOP SCXW185313120\" data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">&nbsp;</span></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5fb5d6bef0014f4f84696858f25b4716x1280x1991.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0337",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following features would you least expect to see in a patient with hereditary spherocytosis?",
      "choices": [
        {
          "id": 1,
          "text": "Pallor"
        },
        {
          "id": 2,
          "text": "Gallstones"
        },
        {
          "id": 3,
          "text": "Splenomegaly"
        },
        {
          "id": 4,
          "text": "Hemoglobinuria"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Hemoglobinuria</strong> is not seen in hereditary spherocytosis where extravascular hemolysis occurs. It is a feature of <strong>intravascular</strong> hemolysis. Pigment gallstones, pallor and splenomegaly can be seen in this condition.</p>\n<p><strong>Cinical features</strong> of extravascular hemolysis include:</p>\n<ul>\n<li>Anaemia</li>\n<li>Jaundice</li>\n<li>Splenomegaly</li>\n</ul>\n<p><strong>Causes </strong>of extravascular hemolysis:</p>\n<ul>\n<li>Hereditary spherocytosis</li>\n<li>Thalassemia</li>\n<li>Sickle cell anaemia</li>\n</ul>\n<p>Note: G6PD deficiency and autoimmune hemolytic anaemia can cause both intravascular and extravascular hemolysis.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA0296",
      "difficulty": "medium"
    },
    {
      "text": "What is the life span of affected red cells in patients with hereditary spherocytosis?",
      "choices": [
        {
          "id": 1,
          "text": "10–20 days"
        },
        {
          "id": 2,
          "text": "20–30 days"
        },
        {
          "id": 3,
          "text": "30–60 days"
        },
        {
          "id": 4,
          "text": "60–90 days"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The<strong> life span</strong> of affected <strong>red cells</strong> in <strong>hereditary spherocytosis</strong> is <strong>10 to 20 days</strong>. The normal life span of RBC is 120 days.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA0291",
      "difficulty": "medium"
    },
    {
      "text": "In a patient with hereditary spherocytosis, MCHC of 38 g/dL was noted. What could be the probable reason for this finding?",
      "choices": [
        {
          "id": 1,
          "text": "Dehydration"
        },
        {
          "id": 2,
          "text": "Increased in Hb content"
        },
        {
          "id": 3,
          "text": "Compensatory erythropoiesis"
        },
        {
          "id": 4,
          "text": "Change in shape"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Increased MCHC</strong> in hereditary spherocytosis is due to <strong>dehydration</strong> caused by the <strong>loss</strong> of <strong>K+</strong> and <strong>H<sub>2</sub>O</strong>.</p>\n<p>MCHC (mean corpuscular hemoglobin concentration) is given by the formula <strong>hemoglobin / PCV </strong>(g/dL). It indicates the amount of hemoglobin per unit volume.</p>\n<p>Note:</p>\n<ul>\n<li>MCV (mean corpuscular volume) is given by the formula PCV / RBC (fL). It denotes the size of the RBCs.</li>\n<li>MCH (mean corpuscular hemoglobin) is given by the formula hemoglobin / RBC (pg). It quantifies the hemoglobin in the RBCs.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA0294",
      "difficulty": "medium"
    },
    {
      "text": "In the following osmotic fragility curve, A occurs in _________.",
      "choices": [
        {
          "id": 1,
          "text": "Beta thalassemia"
        },
        {
          "id": 2,
          "text": "Sickle-cell anaemia"
        },
        {
          "id": 3,
          "text": "Hereditary spherocytosis"
        },
        {
          "id": 4,
          "text": "Iron deficiency anaemia"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Osmotic fragility curve shifts to the&nbsp;<strong data-stringify-type=\"bold\">right</strong>&nbsp;in&nbsp;<strong data-stringify-type=\"bold\">hereditary spherocytosis</strong>.</p>\n<p>In hereditary spherocytosis, the cells are&nbsp;<strong data-stringify-type=\"bold\">spherocytic</strong>&nbsp;in normal plasma (0.9% NaCl) and&nbsp;<strong data-stringify-type=\"bold\">hemolyse</strong>&nbsp;readily at&nbsp;<strong data-stringify-type=\"bold\">higher concentrations</strong>&nbsp;than normal discoid red cells do, hence shifting the curve to the&nbsp;<strong data-stringify-type=\"bold\">right</strong>.</p>\n<p>Osmotic fragility is the susceptibility of the RBC to rupture under osmotic stress. In&nbsp;<strong data-stringify-type=\"bold\">hypotonic</strong>&nbsp;solutions, RBCs&nbsp;<strong data-stringify-type=\"bold\">swell</strong>&nbsp;to become spherical and eventually&nbsp;<strong data-stringify-type=\"bold\">hemolyse</strong>. In the graph, the x-axis represents the saline concentration while the y-axis represents the percentage of red cells that have undergone hemolysis. When osmotic fragility is&nbsp;<strong data-stringify-type=\"bold\">normal</strong>, red cells begin to hemolyse at 0.5% saline, with 50% of hemolysis occuring at 0.40-0.42% saline and complete hemolysis occuring at 0.35% saline as represented in the curve.</p>\n<p>In thalassemia and sickle cell anemia on the other hand, the cells are <strong>resistant</strong> to hemolysis and don&rsquo;t hemolyse unless the concentration of saline is <strong>very low</strong>, shifting the graph to the <strong>left</strong>.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/95a58cb42c2e4626a8a7dbb6c7271e89x1280x1123.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/e0102ad989de48ca8b0b337a96e35e66.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0345",
      "difficulty": "easy"
    },
    {
      "text": "A 7-year-old girl presents with fever and jaundice for 5 days. On examination, splenomegaly is noted. Her lab reports are given below. What is the likely trigger to have caused this condition?<div class='question-desc-html'><p>Hb - 5 g%</p>\n<p>WBC - 1000 /mm3</p>\n<p>Platelets - 45,000 /mm3</p>\n<p>Peripheral smear shows spherocytes</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Parvovirus"
        },
        {
          "id": 2,
          "text": "EBV"
        },
        {
          "id": 3,
          "text": "Plasmodium"
        },
        {
          "id": 4,
          "text": "Meningococcus"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given hemogram showing <strong>pancytopenia</strong> and <strong>spherocytes</strong> in peripheral smear is suggestive of <strong>aplastic crisis</strong> in <strong>hereditary spherocytosis</strong>. It is usually triggered by <strong>parvovirus</strong> infection.</p>\n<p>Parvovirus infects and kills the red cell precursors. This creates a<strong> transient </strong>arrest of erythropoiesis i.e. <strong>aplastic crisis</strong> as the life span of RBCs are shortened. The immune response clears the virus in 1-2 weeks.</p>\n<p><strong>Blood transfusions</strong> may be necessary during <strong>acute phases</strong> of the infection. This crisis can also occur in other hemolytic anaemias. </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA0295",
      "difficulty": "easy"
    },
    {
      "text": "Which amino acid lies at the sixth position of the beta chain of hemoglobin?",
      "choices": [
        {
          "id": 1,
          "text": "Valine"
        },
        {
          "id": 2,
          "text": "Glutamine"
        },
        {
          "id": 3,
          "text": "Glutamate"
        },
        {
          "id": 4,
          "text": "Lysine"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Glutamate</strong> lies at the <strong>6th position</strong> of the <strong>beta chain</strong> of hemoglobin.</p>\n<p><strong>Sickle-cell disease</strong> is caused by a <strong>point</strong> <strong>mutation</strong> in the sixth codon of β-globin. This leads to the <strong>replacement</strong> of a glutamate residue with a <strong>valine</strong> residue.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA0303",
      "difficulty": "medium"
    },
    {
      "text": "A blood sample is taken from a suspected case of sickle cell anaemia. Which of the following properties can be used to differentiate HbS from HbA?",
      "choices": [
        {
          "id": 1,
          "text": "Function"
        },
        {
          "id": 2,
          "text": "Stability"
        },
        {
          "id": 3,
          "text": "Affinity"
        },
        {
          "id": 4,
          "text": "Solubility"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Solubility can be used to differentiate as <strong>HbS</strong> is <strong>less soluble</strong> than <strong>HbA</strong>. The function, stability and affinity of HbS are similar to that of HbA.</p>\n<p>In <strong>HbS</strong>, <strong>glutamic acid</strong>, which is a polar amino acid, is <strong>replaced</strong> by a non-polar amino acid <strong>valine</strong> at the 6<sup>th</sup> position.&nbsp;HbS molecules have the tendency to stack into<strong> polymers</strong> when <strong>deoxygenated</strong>.&nbsp;This process converts the red cell <strong>cytosol</strong> from a free-flowing liquid into a viscous <strong>gel</strong>.&nbsp;This causes a change in the solubility of the hemoglobin.</p>\n<p>The major pathologic manifestations of decreased solubility and polymerisation of HbS are chronic hemolysis, microvascular occlusions, and tissue damage.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA0305",
      "difficulty": "medium"
    },
    {
      "text": "A 35-year-old man was diagnosed to have heterozygous sickle cell trait. What will be the approximate percentage of HbS in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "40%"
        },
        {
          "id": 2,
          "text": "60%"
        },
        {
          "id": 3,
          "text": "50%"
        },
        {
          "id": 4,
          "text": "30%"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>In <strong>heterozygotes</strong>&nbsp;with <strong>sickle-cell trait</strong>, about <strong>40%</strong> of the hemoglobin is <strong>HbS.</strong>&nbsp;The rest of hemoglobin (60%) is HbA.</p>\n<p>Sickle cell trait is a largely asymptomatic condition characterised by heterozygosity seen for HbS (sickle hemoglobin). As only a fraction of the Hb are HbS, polymerization leading to sickling only occurs in <strong>severe and prolonged hypoxia.&nbsp;</strong>Offsprings of 2 heterozygotes have a 1 in 4 chance of having sickle cell <strong>disease</strong>.&nbsp;</p>\n<p>In HbSC heterozygotes, HbS is 50% and HbC is 50%.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA0306",
      "difficulty": "medium"
    },
    {
      "text": "Patients with which of the following combinations of beta-globin chains tend to have a more severe sickle cell disease?",
      "choices": [
        {
          "id": 1,
          "text": "HbA and HbS"
        },
        {
          "id": 2,
          "text": "HbA2 and HbS"
        },
        {
          "id": 3,
          "text": "HbS and HbC"
        },
        {
          "id": 4,
          "text": "HbS and HbF"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Among the given options, the heterozygous combination of <strong>HbS</strong> and <strong>HbC</strong> causes a more severe form of the disease. Overall severity is more in homozygous HbS.&nbsp;</p>\n<p>Severity sequence is <strong>HbSS &gt; HbSC &gt; HbSA &gt; HbSF.</strong></p>\n<p>In <strong>HbC,</strong>&nbsp;<strong>lysine</strong> is substituted for <strong>glutamate</strong> in the sixth amino acid residue of &beta;-globin. The percentage of HbS is 50% in HbSC red cells and 40% in HbAS cells. Moreover, <strong>HbSC</strong> cells tend to lose salt and water and become dehydrated, which increases the intracellular concentration of HbS. Both of these factors <strong>increase</strong> the <strong>tendency</strong> for HbS to <strong>polymerize</strong>. As a result, individuals who are compound heterozygotes for HbS and HbC, have symptomatic sickling disorder (termed HbSC disease). However, it is milder than sickle cell disease (HbSS).</p>\n<p><strong>HbF</strong> <strong>inhibits</strong> the <strong>polymerization</strong> of HbS even more than HbA. Hence, infants do not become symptomatic until they reach 5 or 6 months of age when the level of HbF normally falls.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA0307",
      "difficulty": "medium"
    },
    {
      "text": "In patients with sickle cell anaemia, which of the following factors promote sickling of RBC?",
      "choices": [
        {
          "id": 1,
          "text": "Decreased MCHC"
        },
        {
          "id": 2,
          "text": "HbF type"
        },
        {
          "id": 3,
          "text": "HbC type"
        },
        {
          "id": 4,
          "text": "High pH"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>HbC</strong> <strong>promotes</strong> the <strong>sickling</strong> of RBC, whereas HbF opposes it.</p>\n<p>Factors that promote sickling are:</p>\n<ul>\n<li>Increased MCHC</li>\n<li>Hb C</li>\n<li>Acidic pH</li>\n<li>Hypoxia</li>\n</ul>\n<p><strong>HbF</strong> has a <strong>high affinity</strong> for oxygen than other hemoglobins. Hence, high oxygen content prevents sickling. HbF inhibits the polymerization of HbS. So the infants do not become symptomatic until they reach 5 or 6 months of age when the level of HbF normally falls.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA0309",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following reagents is used for sickling test?",
      "choices": [
        {
          "id": 1,
          "text": "Sodium thiocyanate"
        },
        {
          "id": 2,
          "text": "Sodium chloride"
        },
        {
          "id": 3,
          "text": "Sodium metabisulfite"
        },
        {
          "id": 4,
          "text": "Hydrochloric acid"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The <strong>reagent</strong> used for the <strong>sickling test</strong> is <strong>sodium metabisulfite</strong>. It is an oxygen-consuming reagent,&nbsp;which induces the sickling of red cells in the presence of HbS.&nbsp;</p>\n<p>Sickling test with sodium metabisulfite is used as a <strong>screening</strong> test for sickle cell anaemia.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0364",
      "difficulty": "easy"
    },
    {
      "text": "A 12-year-old girl presents with fever and severe pain in her hands and feet. There is no history of trauma. Her lab reports reveal Hb to be 8.2 g/dL and peripheral smear as shown below. Which of the following parasitic infections is this condition protective against?",
      "choices": [
        {
          "id": 1,
          "text": "P. falciparum"
        },
        {
          "id": 2,
          "text": "P. vivax"
        },
        {
          "id": 3,
          "text": "P. ovale"
        },
        {
          "id": 4,
          "text": "Babesia"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario is suggestive of&nbsp;<strong>sickle cell anaemia.</strong>&nbsp;HbS gives <strong>protection</strong> against<em> <strong>P</strong><strong>lasmodium</strong> <strong>falciparum</strong></em> malaria.&nbsp;</p>\n<p><strong>Hand-foot syndrome</strong>&nbsp;or <strong>dactylitis</strong> of bones of hands and feet is a severe acute inflammatory response seen in sickle cell anaemia.&nbsp;It is caused by <strong>vaso-occlusive</strong> episodes leading to <strong>ischemia</strong> and finally <strong>infarction</strong> of the distal portions of the <strong>extremities</strong>.</p>\n<p>Sickle cells <strong>impair</strong> the <strong>formation</strong> of membrane knobs containing a protein made by <em>P. falciparum</em> called <strong>PfEMP-1</strong>. This <strong>decreases</strong> the <strong>adherence</strong> of infected red cells to the endothelium.</p>\n<p>Individuals with <strong>sickle cell trait</strong> are significantly less likely to have severe disease or to die from malaria. It is because of the increased <strong>phagocytosis</strong> of sickled cells in the spleen, which keeps the <strong>parasite load down</strong>.&nbsp;</p>\n<p>The image given below shows sickle cells seen on peripheral smear in sickle cell anemia.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f89e37ae8f574f5e86ca447ceba81f67x1280x1151.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/75f848107823409a8fa03678f29426ed.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA0304",
      "difficulty": "easy"
    },
    {
      "text": "What happens to the severity of hemolytic anaemia in concurrent sickle cell anaemia and α-thalassemia?",
      "choices": [
        {
          "id": 1,
          "text": "Increases"
        },
        {
          "id": 2,
          "text": "Decreases"
        },
        {
          "id": 3,
          "text": "No change"
        },
        {
          "id": 4,
          "text": "Both cannot co-exist"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The <strong>concurrence</strong> of <strong>sickle cell</strong> anaemia and <strong>&alpha;-thalassemia</strong> results in <strong>less severe hemolytic anaemia</strong>.</p>\n<p><strong>Sickle cell anaemia</strong> is caused by point mutations in &beta; globin synthesis leading to <strong>defective HbS synthesis</strong>. When these RBCs release oxygen, the <strong>HbS polymerises</strong> leading to membrane distortion</p>\n<p><strong>Thalassemia</strong> is due to germline mutations causing <strong>decreased</strong> globin chain synthesis (&alpha; or&nbsp;&beta;). Since these diseases have a different pathogenesis, they <strong>can occur concurrently</strong>.</p>\n<p>In alpha-thalassemia, the <strong>concentration</strong> of <strong>hemoglobin</strong> is <strong>decreased</strong>. Therefore the <strong>concentration</strong> of <strong>HbS</strong> in sickle cell anaemia is also <strong>decreased</strong>. Since HbS molecules should be <strong>close</strong> to each other for <strong>polymerization</strong> to occur. Since there is a <strong>decreased concentration</strong> of HbS in alpha-thalassemia, the HbS molecules are <strong>far</strong> <strong>apart</strong>. So there is a <strong>decreased</strong> <strong>polymerization</strong> of HbS and therefore <strong>less severity</strong> of the disease.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA0308",
      "difficulty": "medium"
    },
    {
      "text": "A 23-year-old patient with sickle cell anaemia presents with fever and malaise. IgM ELISA confirms a parvovirus B19 infection. Which of the following crises will you expect to see in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Aplastic"
        },
        {
          "id": 2,
          "text": "Sequestration"
        },
        {
          "id": 3,
          "text": "Vaso occlusion"
        },
        {
          "id": 4,
          "text": "Acute chest syndrome"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Aplastic crisis</strong> in sickle cell anaemia is caused by <strong>parvovirus B19</strong>.&nbsp;It is&nbsp;a transient arrest of erythropoiesis, usually triggered by an acute parvovirus infection. Parvovirus infects and kills red cell precursors. It occurs in sickle cell disease and other hemolytic anaemias.</p>\n<p><strong>Vaso-occlusive crises</strong> (pain crises) are episodes of <strong>hypoxic injury</strong> and <strong>infarction</strong> that cause severe pain in the affected region. The most commonly involved sites are the bones, lungs, liver, brain, spleen, and penis.&nbsp;<strong>Acute chest syndrome</strong> is a type of vaso-occlusive crisis involving the lungs. It typically presents with fever, cough, chest pain, and pulmonary infiltrates. Pulmonary inflammation may cause blood flow to become sluggish and &ldquo;spleenlike,&rdquo; leading to sickling and vaso-occlusion.&nbsp;</p>\n<p><strong>Sequestration crises</strong> occur in children with intact spleens. Massive entrapment of sickle red cells leads to rapid <strong>splenic enlargement</strong>, hypovolemia, and sometimes shock. Both sequestration crises and acute chest syndrome may be fatal and sometimes require prompt treatment with exchange transfusions.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA0311",
      "difficulty": "easy"
    },
    {
      "text": "During USG examination in a patient with hemolytic anemia, the spleen was not visualized. There is no past history of trauma or surgery. What is the most probable diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Sickle cell anaemia"
        },
        {
          "id": 2,
          "text": "G6PD deficiency"
        },
        {
          "id": 3,
          "text": "Beta-thalassemia"
        },
        {
          "id": 4,
          "text": "Hereditary spherocytosis"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Non-visualisation</strong> of the <strong>spleen</strong> on routine USG is suggestive of <strong>autosplenectomy</strong>, which is seen in <strong>sickle cell anemia</strong>. Splenomegaly is seen in thalassemia and hereditary&nbsp;spherocytosis.</p>\n<p>In <strong>children</strong> with sickle cell anaemia, there is <strong>moderate</strong> <strong>splenomegaly.</strong>&nbsp;This is due to red pulp congestion caused by the entrapment of sickled red cells. As age advances, <strong>chronic erythrostasis</strong> produces hypoxic damage and infarcts. By <strong>adulthood</strong>, the spleen is reduced to a band of fibrous tissue. This process is called&nbsp;<strong>autosplenectomy</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA0310",
      "difficulty": "easy"
    }
  ]
}